World Health Organization Ranking of Antimicrobials According to Their Importance in Human Medicine: A Critical Step for Developing Risk Management Strategies to Control Antimicrobial Resistance from Food Animal Production

Clinical Infectious Diseases

Volumn 63, Issue 8, 2016, Pages 1087-1093

  Collignon, Peter C ^a,b   Conly, John M ^c   Andremont, Antoine ^d   McEwen, Scott A ^e   Aidara Kane, Awa ^f   Griffin, Patricia M ^a   Agerso, Yvonne ^a   Dang Ninh, Tran ^a   Donado Godoy, Pilar ^a   Fedorka Cray, Paula ^a   Fernandez, Heriberto ^a   Galas, Marcelo ^a   Irwin, Rebecca ^a   Karp, Beth ^a   Matar, Gassan ^a   McDermott, Patrick ^a   Mitema, Eric ^a   Reid Smith, Richard ^a   Scott, H Morgan ^a   Singh, Ruby ^a   Dewaal, Caroline Smith ^a   Stelling, John ^a   Toleman, Mark ^a   Watanabe, Haruo ^a   Woo, Gun Jo ^a   more..

^a CANBERRA HOSPITAL   (Australia)

^b The Australian National University   (Australia)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY OF GUELPH   (Canada)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Animals; Antimicrobial resistance; Antimicrobials; Food production; Risk management

Indexed keywords

AMINOCYCLITOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANSAMYCIN DERIVATIVE; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; GLYCOPEPTIDE; GLYCYLCYCLINE DERIVATIVE; KETOLIDE; LINCOSAMIDE; LIPOPEPTIDE; MACROLIDE; MONOBACTAM DERIVATIVE; NITROFURANTOIN; NITROIMIDAZOLE DERIVATIVE; OXAZOLIDINONE DERIVATIVE; PENICILLIN DERIVATIVE; PHOSPHONIC ACID DERIVATIVE; PLEUROMUTILIN ANTIBIOTIC AGENT; POLYMYXIN DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; STREPTOGRAMIN DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; DRUG USE; FOOD INDUSTRY; FOOD SAFETY; HEALTH HAZARD; LIVESTOCK; NONHUMAN; PRIORITY JOURNAL; RISK MANAGEMENT; WORLD HEALTH ORGANIZATION; ANIMAL; DRUG CONTROL; HUMAN;

ANIMALS; ANTI-INFECTIVE AGENTS; DRUG AND NARCOTIC CONTROL; DRUG RESISTANCE, MICROBIAL; FOOD SAFETY; HUMANS; RISK MANAGEMENT; WORLD HEALTH ORGANIZATION;

EID: 84991000766     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw475     Document Type: Conference Paper

References (47)

1. de Kraker ME, Davey PG, Grundmann H; BURDEN study group. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteraemia: estimating the burden of antibiotic resistance in Europe. PLoS Med 2011; 8:e1001104.
2. de Kraker ME, Wolkewitz M, Davey PG, et al. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins. J Antimicrob Chemother 2011; 66:398-407.
3. Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48:1-12.
4. World Health Organization. Critically important antibacterial agents for human medicine for risk management strategies of non-human use: report of a WHO working group consultation. Canberra, Australia, February 2005. Available at: http://apps.who.int/iris/bitstream/10665/43330/1/9241593601-eng.pdf?ua=1. Accessed 1 November 2015.
5. World Health Organization. Critically important antimicrobials for human medicine. Second revision 2009. Copenhagen, Denmark, May 2007. Available at: http:// www.who.int/foodsafety/foodborne-disease/CIA-2nd-rev-2009.pdf. Accessed 1 November 2015.
6. World Health Organization. Critically important antimicrobials for human medicine. Third revision 2011. Oslo, Norway, June 2011. Available at: http://apps.who. int/iris/bitstream/10665/77376/1/9789241504485-eng.pdf. Accessed 1 November 2015.
7. World Health Organization. FifthMeeting of theWHOAdvisory Group on Integrated Surveillance of Antimicrobial Resistance. Bogotá, Colombia, September 2013. Available at: http://www.who.int/foodsafety/areas-work/antimicrobial-resistance/ Exe-summ-Report-AGISAR-5.pdf. Accessed 1 December 2015.
8. Collignon P, Powers JH, Chiller TM, Aidara-Kane A, Aarestrup FM. World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin Infect Dis 2009; 49:132-41.
9. Edo JT, Grave K, Mackay D. One Health: the regulation and consumption of antimicrobials for animal use in the EU. Int Animal Health J 2015; 2:14-6.
10. McDonald's Corporation. McDonald's global vision for antimicrobial stewardship in food animals, March 2015. Available at: http://www.aboutmcdonalds.com/ content/dam/AboutMcDonalds/Sustainability/Antimicrobial-Stewardship- Vision.pdf. Accessed 1 November 2015.
11. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2013. Available at: http://www.cdc.gov/drugresistance/threatreport-2013/index.html. Accessed 29 February 2016.
12. Walsh TR, Weeks J, Livermore DM, et al. Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. Lancet Infect Dis 2011; 11:355-62.
13. Mandal J, Acharya NS, Buddhaptiya D, et al. Antibiotic resistance pattern among common bacterial uropathogens with special reference to ciprofloxacin resistant Escherichia coli. Indian J Med Res 2012; 136:842-9.
14. de Kraker ME, Jarlier V, Monen JC, Heuer OE, van de Sande N, Grundmann H. The changing epidemiology of bacteraemias in Europe: trends from the European Antimicrobial Resistance Surveillance System. Clin Microbiol Infect 2013; 19:860-8.
15. Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016; 16:161-8.
16. Paterson DL, Harris PN. Colistin resistance: a major breach in our last line of defence. Lancet Infect Dis 2016; 16:132-3.
17. World Health Organization. Global action plan on antimicrobial resistance, May 2015. Available at: http://www.who.int/drugresistance/global-action-plan/en/. Accessed 1 November 2015.
18. Cheng AC, Turnidge J, Collignon P, et al. Control of fluoroquinolone resistance through successful regulation, Australia. Emerg Infect Dis 2012; 18:1453-60.
19. Aarestrup FM, Wegener HC, Collignon P. Resistance in bacteria of the food chain: epidemiology and control strategies. Expert Rev Anti Infect Ther 2008; 6:733-50.
20. Guerra B, Fischer J, Helmuth R. An emerging public health problem: acquired carbapenemase-producing microorganisms are present in food-producing animals, their environment, companion animals and wild birds. Vet Microbiol 2014; 171:290-7.
21. European Centre for Disease Prevention and Control, European Food Safety Authority, and European Medicines Agency. ECDC/EFSA/EMA first joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals. Stockholm/Parma/London: ECDC/EFSA/EMA, 2015. EFSA J 2015; 13:4006, 114 p.p.
22. Goossens H, Ferech M, Vander Stichele R, et al. ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005; 365:579-87.
23. Nasrin D, Collignon P, Roberts L, et al. Effect of beta lactam antibiotic use in children on pneumococcal resistance to penicillin: prospective cohort study. BMJ 2002; 324:28-30.
24. World Health Organization. Impacts of antimicrobial growth promoter termination in Denmark. Available at: http://www.who.int/gfn/en/Expertsreport growthpromoterdenmark.pdf. Accessed 1 November 2015.
25. Gottesman BS, Carmeli Y, Shitrit P, Chowers M. Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. Clin Infect Dis 2009; 49:869-75.
26. Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 2004; 10:514-7.
27. Holmes AH, Moore LS, Sundsfjord A, et al. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 2016; 387:176-87.
28. Price LB, Stegger M, Hasman H, et al. Staphylococcus aureus CC398: host adaptation and emergence of methicillin resistance in livestock. MBio 2012; 3: e00305-11.
29. European challenges on antimicrobial resistance from a One Health perspective. Danish EU Presidency meeting, Copenhagen, 14 March 2012. ECDC directors presentation. Available at: http://ecdc.europa.eu/en/aboutus/organisation/ Director%20Speeches/20120314-AMR-presentation-Copenhagen-EUpresidency. pdf. Accessed 30 October 2015.
30. Finley RL, Collignon P, Larsson DG, McEwen SA, Li XZ, et al. The scourge of antibiotic resistance: the important role of the environment. Clin Infect Dis 2013; 5:704-10.
31. Hu X, Zhou Q, Luo Y. Occurrence and source analysis of typical veterinary antibiotics in manure, soil, vegetables and groundwater from organic vegetable bases, northern China. Environ Pollut 2010; 158:2992-8.
32. Zhao L, Dong YH, Wang H. Residues of veterinary antibiotics in manures from feedlot livestock in eight provinces of China. Sci Total Environ 2010; 408:1069-75.
33. Xi C, Zhang Y, Marrs CF, et al. Prevalence of antibiotic resistance in drinking water treatment and distribution systems. Appl Environ Microbiol 2009; 75:5714-8.
34. Kennedy K, Collignon P. Colonisation with Escherichia coli resistant to critically important antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis 2010; 12:1501-6.
35. Food and Drug Administration. 2011 summary report on antimicrobials sold or distributed for use in food-producing animals, September 2014. Available at: http://www.fda.gov/downloads/ForIndustry/UserFees/AnimalDrugUserFeeAct ADUFA/UCM338170.pdf. Accessed 16 November 2015.
36. US Food and Drug Administration. Drug use review, April 2012. Available at: http://www.fda.gov/downloads/Drugs/DrugSafety/InformationbyDrugClass/ UCM319435.pdf. Accessed 16 November 2015.
37. Enne VI. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done? J Antimicrob Chemother 2010; 65:179-82.
38. Van Boeckel TP, Brower C, Gilbert M, et al. Global trends in antimicrobial use in food animals. Proc Natl Acad Sci U S A 2015; 112:5649-54.
39. Collignon P, Voss A. China, what antibiotics and what volumes are used in food production animals? Antimicrob Resist Infect Control 2015; 4:16.
40. World Health Organization. Integrated surveillance of antimicrobial resistance. Guidance from a WHO advisory group. Geneva, Switzerland: WHO, 2013. Available at: http://www.who.int/foodsafety/publications/agisar-guidance/en/. Accessed 24 November 2015.
41. World Health Organization. WHO global principles for the containment of antimicrobial resistance in animals intended for food: report of a WHO consultation with the participation of the Food and Agriculture Organization of the United Nations and the Office International des Epizooties. Geneva, Switzerland. Available at: http://www.who.int/foodsafety/publications/containment-amr/en/. Accessed 4 March 2016.
42. Dutil L, Irwin R, Finley R, et al. Ceftiofur resistance in Salmonella enterica serovar Heidelberg from chicken meat and humans, Canada. Emerg Infect Dis 2010; 16:48-54.
43. Willemsen I, Oome S, Verhulst C, Pettersson A, Verduin K, Kluytmans J. Trends in extended spectrum beta-lactamase (ESBL) producing Enterobacteriaceae and ESBL genes in a Dutch teaching hospital, measured in 5 yearly point prevalence surveys (2010-2014). PLoS One 2015; 10:e0141765.
44. Tysons Foods. Tyson Foods strives to eliminate human antibiotics from broiler chicken flocks by 2017. Available at: http://www.tysonfoods.com/media/ news-releases/2015/04/antibiotics-announcement.aspx. Accessed 1 November 2015.
45. Perdue Foods. Perdue Foods reaches milestone in reducing antibiotic use, sets standard for responsible use. Available at: http://www.perduefarms. com/News-Room/Press-Releases/details.asp?id=1104. Accessed 1 November 2015.
46. Huffstutter PJ. Subway shifting all U.S. meat supplies to no-antibiotics. Reuters Business News. 20 October 2015. Available at: http://www.reuters.com/article/ 2015/10/20/us-usa-subway-antibiotics-idUSKCN0SE2FF20151020#kqUOzH pHHHbLS9rw.97. Accessed 1 November 2015.
47. Guyatt GH, Oxman AD, Vist GE, et al. GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336:924-6.